Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours.
about
Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumorsGene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors.Interventional treatment of the carcinoid syndrome.Histidine decarboxylase and urinary methylimidazoleacetic acid in gastric neuroendocrine cells and tumours.Pheochromocytoma and paraganglioma.NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids.Infection of human enteroendocrine cells with Chlamydia trachomatis: a possible model for pathogenesis in irritable bowel syndrome.Profiling of ileal carcinoids.Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters.Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levelsP2Y2- and P2Y4 purinergic receptors are over-expressed in human colon cancer.Malignant pheochromocytoma: state of the field with future projections.Gene expression in midgut carcinoid tumors: potential targets for immunotherapy.Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status.In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.Histidine decarboxylase, DOPA decarboxylase, and vesicular monoamine transporter 2 expression in neuroendocrine tumors: immunohistochemical study and gene expression analysis.The vesicular monoamine transporter 2 (VMAT2) is expressed by normal and tumor cutaneous mast cells and Langerhans cells of the skin but is absent from Langerhans cell histiocytosis.Vesicular monoamine transporter 2 (VMAT2) expression in hematopoietic cells and in patients with systemic mastocytosis.
P2860
Q28188312-6146BEF9-770C-4BFF-97FA-A4D38CB753CCQ34012005-DD913E90-C481-46A0-AC99-9BB44F9EA367Q35915017-511B77BA-85C4-47CD-8C36-EFE76C54C436Q36373615-AE9985EF-F17B-4020-A046-033A10585CF5Q36467162-C0FF625F-CF87-4A89-B173-D7F09064EB90Q36648990-53777C4A-2CA1-4607-8706-9B622B3EC7D4Q37850303-9A03C870-DC0D-412E-80B6-32513C403732Q38044219-DB8C2DD9-9C0A-4BEB-AC0C-339977A98835Q38602413-1D517DD0-9854-4BBC-BD87-AF408801F339Q38904571-A43C424A-6F85-4401-A769-CB1DC4E0E28FQ40153245-69CFFAF8-04D0-4CC5-9479-09F6918289C2Q40270415-6334AF1F-F43D-45B6-9C94-8BE57F95D148Q40431375-F830EA75-E6F2-46DB-AFA1-72871FE47916Q40968694-0C8606E3-A83E-4EB9-9CA6-D6561A64DBE8Q42161674-FB995C51-B935-4458-A1F9-26FB8507AE88Q46976091-DFBBDA48-6A30-4E49-96A4-2593BBE497B9Q47585008-BEB4F50C-BAD0-4C34-8BD3-D835912738CCQ54647310-83B07F0E-00ED-479B-AAA8-B0620F18CEF1
P2860
Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Differential expression of ves ...... ointestinal endocrine tumours.
@en
Differential expression of vesicular monoamine transporter
@nl
type
label
Differential expression of ves ...... ointestinal endocrine tumours.
@en
Differential expression of vesicular monoamine transporter
@nl
prefLabel
Differential expression of ves ...... ointestinal endocrine tumours.
@en
Differential expression of vesicular monoamine transporter
@nl
P2093
P2860
P50
P356
P1476
Differential expression of ves ...... ointestinal endocrine tumours.
@en
P2093
Andersson E
Andersson P
Erickson JD
Jakobsen AM
Wängberg B
P2860
P304
P356
10.1002/PATH.973
P577
2001-11-01T00:00:00Z